Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
psoriatic arthritis
Biotech
MoonLake nanobody boosts ph. 3 endpoints in psoriatic arthritis
At week 16, 42.1% of patients achieved ACR50, and all secondary clinical endpoints were also met in the placebo-controlled study.
Marissa Russo
Aug 10, 2026 11:00am
Affibody gets izokibep ‘back on track’ after Acelyrin rejection
Jun 5, 2026 10:42am
Acelyrin rebounds with psoriatic arthritis victory
Mar 11, 2024 10:59am
Fierce Biotech Bureau of Investigations seeks ACR poster burglar
Nov 16, 2023 12:59pm
Ventyx stock drops 70% as TYK2 inhibitor psoriasis plans halted
Nov 7, 2023 7:23am
MoonLake shines brighter as IL-17 drug scores latest phase 2 win
Nov 6, 2023 8:14am
